Sarepta shares jump 13%, extending Monday's surge on drug approval

Shares of Sarepta Therapeutics jumped more than 10 percent in Tuesday morning trade after closing higher Monday on government approval of its drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.